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Abstract To compare utilization of non-invasive
ischemic testing, invasive coronary angiography
(ICA), and percutaneous coronary intervention (PCI)
procedures before and after introduction of 64-slice
multi-detector row coronary computed tomographic
angiography (CCTA) in a large urban primary and
consultative cardiology practice. We utilized a review
of electronic medical records (NotesMD
) and the
electronic practice management system (Megawest
)
encompassing a 4-year period from 2004 to 2007
to determine the number of exercise treadmill
(TME), supine bicycle exercise echocardiography
(SBE), single photon emission computed tomography
(SPECT) myocardial perfusion stress imaging (MPI),
coronary calcium score (CCS), CCTA, ICA, and PCI
procedures performed annually. Test utilization in the
2 years prior to and 2 years following availability of
CCTA were compared. Over the 4-year period
reviewed, the annual utilization of ICA decreased
45%(2,083proceduresin2004vs.1,150proceduresin
2007, P\0.01) and the percentage of ICA cases
requiringPCIincreased(19%in2004vs.28%in2007,
P\0.001). SPECT MPI decreased 19% (3,223 in
2004 vs. 2,614 in 2007 P\0.02) and exercise stress
treadmilltestingdecreased49%(471in2004vs.241in
2007 P\0.02). Over the same period, there were no
signiﬁcant changes in measures of practice volume
(ofﬁce and hospital) or the annual incidence of PCI
(405 cases in 2004 vs. 326 cases in 2007) but a higher
percentage of patients with signiﬁcant disease under-
going PCI 19% in 2004 vs. 29% in 2007 P\0.01.
Implementation of CCTA resulted in a signiﬁcant
decrease in ICA and a corresponding signiﬁcant
increase in the percentage of ICA cases requiring
PCI, indicating that CCTA resulted in more accurate
referral for ICA. The reduction in unnecessary ICA is
associated with avoidance of potential morbidity and
mortality associated with invasive diagnostic testing,
reduction of downstream SPECT MPI and TME as
well as substantial savings in health care dollars.
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Abbreviations and acronyms
CAD Coronary artery disease
CCS Coronary calcium score
CCTA Coronary computed tomographic
angiography
CLCD California local coverage determination
CT Computed tomography
ECG Electrocardiogram
ICA Invasive coronary angiography
MDCT Multidetector computed tomography
MPI Myocardial perfusion imaging
PCI Percutaneous coronary intervention
SBE Supine bicycle exercise echocardiography
SPECT Single proton emission computed
tomography
TME Treadmill exercise testing
Introduction
Cardiac risk stratiﬁcation and identiﬁcation of
patients requiring intensive medical therapy versus
those who might beneﬁt from revascularization has in
part relied on myocardial perfusion imaging [1, 2].
The substantial morbidity, mortality, and economic
costs associated with coronary artery disease (CAD)
have stimulated the development and adoption of
alternative methods. Even though several prospective
studies have concluded that MPI for patients without
limiting symptoms can serve as a gatekeeper to ICA
[3–7] there is an opportunity for more speciﬁc and
sensitive referral for invasive angiography.
Noninvasive coronary computed tomographic
angiography (CCTA), which visualizes coronary
artery stenosis directly (rather than ischemia), has
been proposed as an alternative noninvasive imaging
modality for evaluation of patents with known or
suspected CAD [8]. Studies comparing 64-slice
CCTA to invasive coronary angiography (ICA) as
the gold standard have reported a high ([95%)
negative predictive value (i.e., ability to exclude the
presence of coronary atherosclerosis) and high diag-
nostic sensitivity for identifying stenosis in the
proximal and mid segments ([1.5 mm in diameter)
of the main coronary arteries [9–15]. Despite the
potential of CCTA in the evaluation of patients, great
concern has been expressed regarding the possibility
that CCTA will result in increased testing or layering
of tests [16].
Since there is little data regarding the impact of
CCTA on subsequent downstream test we assessed
the effect of CCTA on utilization of other non
invasive tests in a ‘‘real world setting’’, a 17 member
cardiology group (Cardiovascular Medical Group of
Southern California, Beverly Hills California). We
conducted a retrospective review of practice volume
(new patient and ofﬁce consultations, follow-up
ofﬁce visits, hospital admissions and consultations,
follow-up hospital visits), and the number of non-
invasive (ECG, TME, SBE, SPEC MPI, CCS, CCTA)
and invasive procedures (ICA, PCI) performed
annually for the ﬁrst 2 years in which CCTA was
available (2006–2007) and the two prior years (2004–
2005).
Methods
Patients and data collection
To determine the number of non-invasive and
invasive procedures performed during the period
from January 1, 2004 through December 31, 2007,
billing codes for non-invasive (CCTA, MPI, SBE,
TME) and invasive (ICA, PCI) procedures were
identiﬁed and used to query the practice management
system (Megawest
). Additionally, the practice man-
agement system was queried for practice demograph-
ics each year (new patient and ofﬁce consultations,
follow-up ofﬁce visits, hospital admissions and
consultations, follow up hospital visits).
Multidetector computed tomography
CCTA became available in the practice in late 2005
with the ﬁrst full year of operation in 2006. CCTA
generally was performed in patients determined to be
at intermediate risk by the referring cardiologist and
with indications as outlined in the California
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CT [16]. Only patients without contraindication to
iodinated contrast agents were tested. The use of
CCTA by individual physicians, as the ﬁrst test
compared to MPI-SPEC varied among physicians and
over the years with a tendency to broader use and
more frequent use as the ﬁrst test in later years.
Data acquisition was performed using a 64-slice
multidetector computed tomography (MDCT) (Light-
Speed
 VCT 64-Slice scanner, GE Medical systems).
To avoid motion artifacts caused by elevated heart
rate, prior to the procedure patients routinely received
50–100 mg metoprolol orally several hours prior to
the procedure, followed by up to 100 mg of intrave-
nous metoprolol as needed to achieve HR\60 bpm.
All patients had oral hydration before and after
the study. Nitroglycerine spray (0.4 mcg) was admin-
istered just before the test. After a noncontrast
scan using 2.5 mm thick slices to measure the CCS,
60–100 mg intravenous contrast (Visipaque
 (iodix-
anol) or Omnipaque
 (iohexol), GE Healthcare) was
infused. Triggered by aortic contrast aorta opaciﬁca-
tion, CT acquisition for CCTA was performed during
a breath-hold. Detector collimation was set at 64
channels 9 0.625 mm/slice, gantry rotation speed at
375 ms per rotation, and tube voltage 100–140 kV
(depending on the patient’s body weight) at a current
of 350–750 mA with retrospective helical reconstruc-
tion and dose modulation or prospective scanning.
Image data sets were analyzed using multiplanar
reconstruction, volume rendering, and vessel analysis
software packages (AW 4.3 and 4.4, GE Medical
Systems); this technology allowed reconstructed slice
thickness of approximately 0.6 mm.
The CCS was assessed using semi-atomically
(SmartScore 3, GE Medical Systems. A calciﬁed
lesion was deﬁned as the presence of C1 lesion of C3
pixels with a peak Hounsﬁeld unit (HU) density of
[130. The Agaston score for determination of the
CCS was calculated as: area of calciﬁcation 9 peak
density [17].
All CCTA angiograms were evaluated by readers
meeting level III experience as deﬁned by ACC/AHA
criteria [18] and reported according to SCCT criteria
[19]. Study quality was determined on the basis of
motion artifact and contrast-to-noise ratio. After
qualitative assessment, a lesion was evaluated as
normal, 0–25, 26–50, 51–75, [75% and absence of
contrast opaciﬁcation of the coronary artery lumen
was considered to represent total coronary occlusion
or subtotal occlusion. Non calciﬁed plaque burden
was evaluated as none, mild, moderate or severe and
the CCS score was reported for each CCTA. The
attending Cardiologist independently decided on
downstream testing or testing prior to CCTA.
Invasive coronary angiography
ICA was performed by the Judkins’ technique.
Standard projections were obtained after intracoro-
nary injection of Visipaque
 (iodixanol) or Omni-
paque
 (iohexol) (GE Healthcare). Decisions for
percutaneous coronary intervention were made inde-
pendently by the interventional cardiologist who
reviewed all non invasive testing information, the
clinical history before proceeding with PCI.
Data analysis
Annual utilization and practice demographics were
summarized in an Excel (Microsoft) spreadsheet. For
each parameter, a linear regression analysis was
performed to assess the statistical signiﬁcance of the
trend over the 4-year period. Bar charts were
constructed to graphically represent utilization of
both non-invasive and invasive diagnostic procedures
for all 4 years.
Results
Annual practice demographics and procedure utiliza-
tion rates for the period from 2004 to 2007 are
summarized in Table 1, and annual utilization of non-
invasive and invasive procedures is depicted in
Figs. 1 and 2. During the study period, there were
no signiﬁcant changes in indicators of practice
volume including ofﬁce and hospital patient visits
admissions and consultations. Also the number of
ECGs another measure of general ofﬁce activity did
not change signiﬁcantly.
During 2006, the ﬁrst full year of availability,
1,405 CCTA studies were performed; in the second
full year, the number of CCTA studies decreased
(from 1,405 to 945). Increased utilization of CCTA
was associated with a signiﬁcant 49% decrease in
TMT exercise tests (471 in 2004 vs. 241 in 2007,
P = 0.023) and signiﬁcant 19% reduction in SPEC
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but had no signiﬁcant impact on SBE with a non
signiﬁcant trend upwards.
Over this time, increased utilization of CCTA was
associated with a signiﬁcant 45% decrease in ICA
procedures (2,083 in 2004 vs. 1,150 in 2007,
P\0.012) but had no signiﬁcant impact on PCI
incidence (405 in 2004 vs. 326 in 2007). Implemen-
tations of CCTA in the ofﬁce also was associated
with a signiﬁcant 53% increase in the proportion of
ICA undergoing PCI (19% in 2004 vs. 29% in 2007
P = 0.008).
Overall procedures, including CCTA, decreased.
Comparing all procedures from 2004 to 2007, there
were 230 less TMT, 609 less SPECT scans, 933 less
Table 1 Utilization data,
2004–2007
N/A not applicable, NS not
signiﬁcant
2004 2005 2006 2007 P-value
Practice demographics
New patients and ofﬁce consults 3,998 3,780 3,665 3,665 NS
Follow-up ofﬁce visits 27,857 25,837 26,384 27,401 NS
Hospital admissions and consultations 3,416 2,878 2,773 3,468 NS
Hospital visits 18,087 15,517 13,593 16,200 NS
Non-invasive procedures
ECG 15,679 13,358 13,903 14,670 NS
TME 471 401 272 241 0.023
SBE 1,116 952 1,146 1,223 NS
SPECT 3,223 3,139 2,810 2,614 0.021
Calcium score 0 30 715 1132 0.045
CCTA 0 74 1405 945 N/A
Invasive procedures
ICA 2,083 1,848 1,589 1,150 0.012
PCI 405 457 425 326 NS
Stents 352 379 386 275 NS
PTCA 53 78 39 51 NS
PCI/ICA (%) 19% 25% 27% 28% 0.008
Fig. 1 Utilization of non-invasive diagnostic procedures from
2004 to 2007. Changes in utilization of cardiac testing from
2004 to 2007. CCTA ﬁrst full year of implementation was in
2006. SPECT MPI utilization fell 19% and TME fell 49%
between the years 2004 and 2007
Fig. 2 Utilization of invasive procedures from 2004 to 2007.
The number of invasive coronary angiogram fell 45% between
the years 2004 and 2007 following the implementation of
CCTA in the year 2006. However, the incidence of PCI
remained stable
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CTA. Thus 1,851 less procedures were offset by an
increase in 945 CTA procedures. The overall revenue
of the practice when considering the addition of
CCTA and reduction in other non-invasive testing
was within 10% each year and although lower in later
years changes did not reach statistical signiﬁcance.
Discussion
Once 64-slice MDCT was implemented, CCTA was
rapidly adopted within the practice. During the ﬁrst
full year of availability, 1,405 CCTA procedures
were performed. During the second year, fewer
CCTA procedures were performed as other commu-
nity CTs became available and as cardiologists
became familiar with indications and utility of CCS
testing. Increased reliance on CCS might have played
a role in a lower second year volume of CCTA and
going forward physicians focused on measurable
plaque burden and altered their medical approach.
We have previously reported in this cohort that the
ﬁndings of calciﬁed and non-calciﬁed plaque on
Cardiac CT lead to a change in medical strategy for
CAD with aggressive reduction of LDLs, this despite
near normal LDL values at baseline [20, 21].
The adoption of CCTA was also associated with a
signiﬁcant reduction in SPECT MPI, suggesting that
CCTA replaced SPECT MPI to some extent. The
reduction in SPECT MPI may be explained by a shift
in diagnostic paradigm in which CCTA was per-
formed as a ﬁrst line test instead of SPECT MPI for
evaluation of patients with intermediate pretest risk
of CAD, consistent with current appropriateness
criteria [8, 18]. Further, the strong negative predict-
ability of CCTA would support a decreased need for
downstream SPECT MPI [10, 22]. Also, the number
of stress echocardiograms performed in the last
2 years of the study is greater than the ﬁrst 2 years,
most likely reﬂecting some substitution of SPECT
MPI to stress echocardiography, perhaps due to the
desire to avoid a second test utilization radiation.
The reduced number of patients referred for
invasive coronary angiography and SPECT MPI
was partially offset by the number of patients getting
CCTA, Calcium scores. However, this resulted in a
substitution of very high cost invasive coronary
angiography by lower cost ofﬁce based testing. Since
diagnostic cardiac catheterization is associated with
severe adverse events in 0.7–1.5% of patients and
associated deaths in 0.07% the avoidance of unnec-
essary cardiac catheterization in subjects at relatively
low risk of cardiac events is clinically signiﬁcant and
with substantial cost savings [23–25].
Others have predicted or have estimated that the
potential reductions in myocardial perfusion imaging
and invasive coronary angiography might be consid-
erable in the setting of the utilization of CCTA as the
ﬁrst test for the intermediate risk patient or the patient
with acute coronary syndrome [26–29]. Such esti-
mates suggest reductions in excess of 74%. [26].
However, this is the ﬁrst report in a ‘‘real world’’
uncontrolled setting which documents dramatic
reductions in ICA and simultaneous reduced down-
stream testing of SPECT MPI and TME. Even more
appropriate and cost efﬁcient testing might be
achievable by only considering patients for provoca-
tive testing who have failed medical management and
or have suspicious narrowing’s on CCTA that require
invasive coronary for clariﬁcation or intervention.
In this practice, implementation of CCTA was
associated with a signiﬁcant 45% decrease in ICA
over the study period (from 2,083 procedures in 2004
to 1,150 in 2007, P = 0.012) but had no signiﬁcant
impact on the number of percutaneous revasculari-
zation procedures performed. As a result, implemen-
tation of CCTA was associated with a signiﬁcant 53%
increase (P = 0.008) in the proportion of ICA studies
showing signiﬁcant angiographic narrowing’s result-
ing in the need for percutaneous coronary interven-
tion. This implies that there was more accurate
detection of disease that ultimately underwent PCI
with fewer patients with normal or non occlusive
disease undergoing invasive coronary angiography.
Following publication of the COURAGE trial in the
spring of 2007 [30] this practice experienced a trend
toward reduced incidence of PCI (425 in 2006 vs. 326
in 2007) which did not achieve statistical signiﬁ-
cance. Further evaluation will need to assess utiliza-
tion rates over the next few years to determine
whether there is a signiﬁcant lasting change in the
intervention strategy and resulting impact on ICA and
PCI utilization. Finally, this study performed in a
private practice cardiology group, parallels a univer-
sity medical center study which showed a 30%
decrease in non-invasive imaging after introduction
of CCTA [31]. However, in that study there was a
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and also decisions may have been controlled by
multiple individuals in an academic setting thus
confounding the ability to implement and measure an
opportunity to reduce the incidence of invasive
angiography.
The limitations of our study need consideration:
(1) The trends in noninvasive and invasive proce-
dures reported in this study should be viewed with
some caution, given the short observation period
(2 years before and 2 years after installation of the
64-slice MDCT) and the potential confounding
factors of an uncontrolled retrospective study in the
setting of concerns about late stent stenosis [32]
improved medical management [33, 34] and modest
trends towards general reduction in both invasive
angiography and PCI in similar practices of approx-
imately 10% (MedAxiom, Neptune Beach Florida-
private communication). The utilization of angiogra-
phy is dynamic and under many inﬂuences and
therefore CCTA may not solely account for the
reduction found in this study. (2) The effects of
availability of the calcium score on downstream
testing independent of CCTA cannot be determined
from this study. (However, identiﬁcation of non
calciﬁed plaque found on CCTA enhanced lipid
management [20]). (3) The ﬁndings of a normal or
non occlusive CCTA may have lead to fewer MPI-
SPECT testing and invasive coronary angiography
downstream over the entire 4 years once signiﬁcant
occlusive CAD was excluded. Thus, the ability to
analyze each year effects sequential is impaired.
Conclusions
Despite these limitations, the dramatic reduction in
ICA observed obviates the fear that the anatomic
knowledge of asymptomatic coronary narrowing’s
would lead to increased invasive angiography or
more interventions. To the contrary, the introduction
of non-invasive CT angiography was associated with
a 45% decrease in invasive coronary angiography
particularly among those not requiring PCI. In this
‘‘real world’’ uncontrolled setting there was also a
decrease (19%) in nuclear perfusion exams and the
opportunity for even greater reductions in non-
invasive testing. Finally in view of demonstrated
reduction of reduction exposure of 90% [35], CCTA
with its strong negative predictability, simultaneous
capacity not to miss serious disease and ability to
discern those who might beneﬁt from medical versus
an invasive strategy is an attractive choice as the ﬁrst
test for the intermediate risk patient. Prospective
multicenter control trials are warranted to evaluate
the opportunity to reduce the rate of overall cardiac
imaging procedures, to redeﬁne the utilization and
choice of non invasive testing, to ﬁnd the best
pathway to avoid redundant layering of testing and to
be sure the right patient gets referred for invasive
coronary angiography.
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